The following data is part of a premarket notification filed by Icn Pharmaceuticals, Inc. with the FDA for Immuchem Gal-mw Ea.
Device ID | K951329 |
510k Number | K951329 |
Device Name: | IMMUCHEM GAL-MW EA |
Classification | Enzymatic Methods, Galactose |
Applicant | ICN PHARMACEUTICALS, INC. 3300 HYLAND AVE. Costa Mesa, CA 92626 |
Contact | Robin J Hellen |
Correspondent | Robin J Hellen ICN PHARMACEUTICALS, INC. 3300 HYLAND AVE. Costa Mesa, CA 92626 |
Product Code | JIA |
CFR Regulation Number | 862.1310 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 1995-03-23 |
Decision Date | 1995-11-09 |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00840239014894 | K951329 | 000 |
00840239014887 | K951329 | 000 |
00840239014870 | K951329 | 000 |
00840239014863 | K951329 | 000 |
00817830023129 | K951329 | 000 |
00817830023112 | K951329 | 000 |
00817830023105 | K951329 | 000 |
00817830023099 | K951329 | 000 |